Evaluation of CD24 and CD44 as cancer stem cell markers in squamous cell carcinoma and epithelial dysplasia of the oral cavity by q- RT-PCR
Open Access
- 1 January 2020
- journal article
- Published by Medknow in Dental Research Journal
- Vol. 17 (3) , 208-212
Abstract
Squamous cell carcinoma (SCC) is the most common cancer of the oral cavity and may be preceded by dysplastic epithelial lesion. Oral SCC (OSCC) contains a rare subset of cancer cells with self-renewal ability, termed as cancer stem cells (CSCs). CD24 and CD44 as CSC markers are cell surface glycoproteins. These markers contribute to the onset, maintenance, and extension of tumor growth, as well as angiogenesis. In the present study, these two markers were simultaneously evaluated to provide a specific phenotype for carcinogenesis process in oral cavity. In this analytical-cross-sectional study, the expression of CD24 and CD44 genes was evaluated in 45 OSCCs (20 low-grade and 25 high-grade) and 15 oral epithelial dysplasia specimens by real-time quantitative reverse transcription polymerase chain reaction. Kruskal–Wallis and Mann–Whitney U-test, Kendall, and Spearman tests were used for statistical analysis. The significance level was considered <0.05. High expression of both markers genes was reported in two-thirds of samples. There was no significant difference between studied groups in gene expression of CD24 and CD44 whereas statistically significant association between CD24 and CD44 was observed in all three groups. This correlation was more significant in OSCC groups (P < 0.001). High expression of CSC markers in OSCC and oral epithelial dysplasia revealed the importance of accurate examination of dysplastic lesions with high expression of these markers and the possibility of malignant transformation. Regarding a significant association of two markers, further studies are necessary to provide a specific phenotype (CD44 high CD24 high) for these lesions.Keywords
This publication has 17 references indexed in Scilit:
- Prognostic relevance of low-grade versus high-grade FIGO IB1 squamous cell uterine cervical carcinomasJournal of Cancer Research and Clinical Oncology, 2019
- Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parametersArchives of Oral Biology, 2017
- CD24 + tumor-initiating cells from oral squamous cell carcinoma induce initial angiogenesis in vivoMicrovascular Research, 2017
- CD44v3+/CD24− cells possess cancer stem cell-like properties in human oral squamous cell carcinomaInternational Journal of Oncology, 2015
- Immunohistochemical study of CD44s expression in oral squamous cell carcinoma-its correlation with prognostic parametersJournal of Oral and Maxillofacial Pathology, 2014
- CD44+/CD133+ immunophenotype and matrix metalloproteinase‐9: Influence on prognosis in early‐stage oral squamous cell carcinomaHead & Neck, 2013
- SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- PhenotypeBMC Cancer, 2010
- CD44s and CD44v6 Expression in Head and Neck EpitheliaPLOS ONE, 2008
- p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified EpitheliaCell, 2007
- Nuclear Dynamics of PCNA in DNA Replication and RepairMolecular and Cellular Biology, 2005